Interneuron regulatory update

Interneuron Pharmaceuticals Inc. (IPIC) IPIC received U.S. Patent No. 5,403,851 covering a class of melatonin analogs that include IP 100-9, a potential sleeping aid. The Lexington, Mass., company is ...